Interpreting variants of uncertain significance (VUS) for their effect on protein function, and therefore for the risk of developing cancer, has become a challenge in clinical practice for genetic counselling services. The present work combines structural bioinformatics and systems biology based mathematical modelling approaches with the aim of determining the pathogenicity of the mutation c.5434C->G (p.Pro1812Ala) in the BRCA1 gene (detected in a patient from a high risk family) and also to mechanistically understand the effect of this mutation in DNA damage response, a key process in cancer development. The results obtained showed that this mutation prevents the interaction of BRCA1 with key proteins of the cell cycle, subsequently impairing BRCA1-dependent induction of cell cycle arrest. The comparison of the molecular mechanisms associated with the native BRCA1 protein and the mutated variant function in DNA damage response showed that the latter undergoes a reduction in its ability to modulate pathways that are critical for DNA repair and cell cycle control. Therefore, this variant will not be able to exert its tumor suppressive action. Interestingly, these conclusions can be extrapolated to all mutations that, like c.5434C>G (p.Pro1812Ala) BRCA1, cause loss of BRCT domain activity.
Methods
The assessment of the physiological consequences of the c.5434C->G (p.Pro1812Ala) mutation with regard to its predisposition to develop cancer was approached by two complementary computational perspectives: a structural approach and a systems biology based functional approach.
Structural bioinformatics analysis
A three-dimensional structure of the BRCA1 protein was modelled after experimentally obtained structures contained in PDB, taking into account the changes induced by the mutation according to published literature (10, 11) . Then, a molecular dynamics simulation in a system of interacting particles was run to (Continued on page 3) simulate the variability of the BRCA1 in the cytoplasm and predict its time evolution. The resulting structures with the lowest values of free energy were selected, under the assumption that they are more stable and, hence, may be found in vivo. This exercise was conducted using CHARMM22 (12) force field and calculating the partial charges through the Gasteiger method.
The presence of significant structural changes in the BRCA1 protein was detected through statistical parameters and subjective assessment after visualization and the stability of the mutated protein was determined based on certain key values, including potential energy, RMSD, and Ramachandran outliers. The predictions were compared with the conclusions of published studies.
Systems biology based functional approach
Therapeutic Performance Mapping System (TPMS) technology (Anaxomics Biotech, Barcelona) (13) was applied to generate and analyze mathematical models able to simulate in silico DNA damage response The different biological processes and protein interaction altered by the studied mutation are summarized in Table 1 .
Overall, the comparison between the MoAs of the full-length BRCA1 and its mutated variant shows that the latter undergoes a drastic reduction in its ability to modulate a number of proteins and pathways which are critical for DNA repair and cell cycle control.
Discussion
In order to investigate the hypothetically pathogenic role of the BRCA1 c.5434C->G (p.Pro1812Ala) mutation, a study was carried out using computational methods. A structural model was created and it was assessed from a functional and systems biology point of view. But binding affinity and stability were substantially modified, which could alter the conformational equilibrium and therefore affect the protein's function in vivo (11) .
As a result of a dysfunctional BRCT domain, the mutated protein cannot carry out its role in DNA damage response and cell cycle regulation.
BRCA1 activity that depends on proteins that interact with other domains, such as interaction of the RING domain with the BARD1 protein, is not expected to be affected by this mutation (31).
In the c.5434C->G (p.Pro1812Ala) variant, p53
is not activated by the altered BRCT domain. The initiation of the apoptotic response may therefore be compromised (24) . Although this process will be much more fragile and sensitive to future mutations, it is expected that BRCA1 will retain a certain ability to stop 
